How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?

被引：0
|
作者：
Zheng, Lucy [1 ]
Zheng, X. Long [1 ]
机构：
[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd,Delp 5016, Kansas City, KS 66160 USA
来源：
ANNALS OF BLOOD | 2023年 / 8卷
关键词：
PLASMA-EXCHANGE; REFRACTORINESS; MORTALITY; ADAMTS13;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point
    Poullin, P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (04) : 380 - 385
  • [42] The standard of care for immune thrombotic thrombocytopenic purpura today
    Zheng, X. Long
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1864 - 1871
  • [43] Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
    Knoebl, Paul
    Cataland, Spero
    Peyvandi, Flora
    Coppo, Paul
    Scully, Marie
    Hovinga, Johanna A. Kremer
    Metjian, Ara
    de la Rubia, Javier
    Pavenski, Katerina
    Edou, Jessica Minkue Mi
    De Winter, Hilde
    Callewaert, Filip
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (02) : 479 - 484
  • [44] Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura
    Reddy, P
    Deauna-Limayo, D
    Cook, J
    Ganguly, S
    Blecke, C
    Bodensteiner, D
    Skikne, B
    Sahud, M
    ANNALS OF HEMATOLOGY, 2005, 84 (04) : 232 - 235
  • [45] Thrombotic thrombocytopenic purpura treatment in year 2000
    Rock, G
    Porta, C
    Bobbio-Pallavicini, E
    HAEMATOLOGICA, 2000, 85 (04) : 410 - 419
  • [46] ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
    Zheng, X. Long
    Vesely, Sara K.
    Cataland, Spero R.
    Coppo, Paul
    Geldziler, Brian
    Iorio, Alfonso
    Matsumoto, Masanori
    Mustafa, Reem A.
    Pai, Menaka
    Rock, Gail
    Russell, Lene
    Tarawneh, Rawan
    Valdes, Julie
    Peyvandi, Flora
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2496 - 2502
  • [47] Emerging therapeutics for the treatment of thrombotic thrombocytopenic purpura
    Scully, Marie
    Westwood, John-Paul
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (10): : 577 - 584
  • [48] Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura
    Patriquin, Christopher J.
    Thomas, Mari R.
    Dutt, Tina
    McGuckin, Siobhan
    Blombery, Piers A.
    Cranfield, Tanya
    Westwood, John P.
    Scully, Marie
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (05) : 779 - 785
  • [49] Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura
    Pavan S. Reddy
    Delva Deauna-Limayo
    James D. Cook
    Siddhartha S. Ganguly
    Carol Blecke
    David C. Bodensteiner
    Barry S. Skikne
    Mervin A. Sahud
    Annals of Hematology, 2005, 84 : 232 - 235
  • [50] Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura
    Perrone, Salvatore
    Passucci, Mauro
    La Barbera, Elettra Ortu
    Capriata, Marcello
    Ferretti, Antonietta
    Mecozzi, Alessandra
    Giovangrossi, Piera
    Equitani, Francesco
    Cimino, Giuseppe
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (03) : 499 - 504
12345